doi:0.3969/j.issn.1006-7795.2023.05.001

［1］Webber L, Davies M, Anderson R, et al. ESHRE guideline: management of women with premature ovarian insufficiency［J］. Hum Reprod, 2016, 31(5): 926－937.
［2］Giri R, Vincent A J. Prevalence and risk factors of premature ovarian insufficiency/early menopause［J］. Semin Reprod Med, 2020, 38(4/5): 237－246.
［3］Rebar R W, Keator C S. Expanding our knowledge of premature ovarian insufficiency［J］. Fertil Steril, 2021, 115(2): 328－329.
［4］De Vos M, Devroey P, Fauser B C. Primary ovarian insufficiency［J］. Lancet, 2010, 376(9744): 911－921.
［5］Vogt E C, Real F G, Husebye E S, et al. Premature menopause and autoimmune primary ovarian insufficiency in two international multi-center cohorts［J］. Endocr Connect, 2022, 11(5): e220024.
［6］WHO. China Source: Globocan 2020 ［EB/OL］.(2021-03）［2023-06-06］. https://gco.iarc.fr/today/data/factsheets/populations/160-china-fact-sheets.pdf.
［7］Anderson　R A, Amant F, Braat D, et al. ESHRE guideline: female fertility preservation［J］. Hum Reprod Open, 2020, 2020(4): hoaa052.
［8］Practice Committee of the American Society for Reproductive Medicine. Fertility preservation in patients undergoing gonadotoxic therapy or gonadectomy: a committee opinion［J］. Fertil Steril, 2019, 112(6): 1022－1033.
［9］University of Oxford. Oxford centre for evidencebased medicine: levels of evidence (March 2009)［EB/OL］.（2009-03)［2023-06-06］. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march－2009.
［10］首都医科大学附属北京妇产医院, 中国人体健康科技促进会生育力保护与保存专业委员会. 卵巢组织冻存移植技术规范团体标准［J］. 中国全科医学, 2023, 26(23): 2836－2841.
［11］国际妇科内分泌学会中国妇科内分泌学分会及共识专家. 卵巢组织冻存与移植中国专家共识［J］. 中国临床医生杂志, 2018, 46(4): 496－500.
［12］Ruan X Y. Chinese Society of Gynecological Endocrinology affiliated to the International Society of Gynecological Endocrinology guideline for ovarian tissue cryopreservation and transplantation［J］. Gynecol Endocrinol, 2018, 34(12): 1005－1010.
［13］Dolmans M M, Von Wolff M, Poirot C, et al. Transplantation of cryopreserved ovarian tissue in a series of 285 women: a review of five leading European centers［J］. Fertil Steril, 2021, 115(5): 1102－1115.
［14］Karavani G, Vedder K, Gutman-Ido E, et al. Prior exposure to chemotherapy does not reduce the in vitro maturation potential of oocytes obtained from ovarian cortex in cancer patients［J/OL］. Hum Reprod. (2023－07－06)［2023-06-06］. https://pubmed.ncbi.nlm.nih.gov/37414543/.
［15］Corkum K S, Laronda M M, Rowell E E. A review of reported surgical techniques in fertility preservation for prepubertal and adolescent females facing a fertility threatening diagnosis or treatment［J］. Am J Surg, 2017, 214(4): 695－700.
［16］Beckmann M W, Dittrich R, Lotz L, et al. Fertility protection: complications of surgery and results of removal and transplantation of ovarian tissue［J］. Reprod Biomed Online, 2018, 36(2): 188－196.
［17］Ruan 　X Y, Cheng J J, Du J, et al. Analysis of fertility preservation by ovarian tissue cryopreservation in pediatric children in China［J］. Front Endocrinol (Lausanne), 2022, 13: 930786.
［18］Cheng J J, Ruan X Y, Du J, et al. Ovarian tissue cryopreservation for a 3-year-old girl with Mosaic Turner syndrome in China: first case report and literature review［J］. Front Endocrinol (Lausanne), 2022, 13: 959912.
［19］Khattak H, Malhas R, Craciunas L, et al. Fresh and cryopreserved ovarian tissue transplantation for preserving reproductive and endocrine function: a systematic review and individual patient data meta-analysis［J］. Hum Reprod Update, 2022, 28(3): 400－416.
［20］Gellert S E, Pors S E, Kristensen S G, et al. Transplantation of frozenthawed ovarian tissue: an update on worldwide activity published in peer-reviewed papers and on the Danish cohort［J］. J Assist Reprod Genet, 2018, 35(4): 561－570.
［21］Dolmans M M, Iwahara Y, Donnez J, et al. Evaluation of minimal disseminated disease in cryopreserved ovarian tissue from bone and soft tissue sarcoma patients［J］. Hum Reprod, 2016, 31(10): 2292－2302.
［22］Shapira M, Raanani H, Barshack I, et al. First delivery in a leukemia survivor after transplantation of cryopreserved ovarian tissue, evaluated for leukemia cells contamination［J］. Fertil Steril, 2018, 109(1): 48－53.
［23］Nurmio M, Asadi-Azarbaijani B, Hou M, et al. Effect of previous alkylating agent exposure on follicle numbers in cryopreserved prepubertal and young adult ovarian tissue after long-term xenografting［J］. Cancers (Basel), 2022, 14(2): 399.
［24］Chevillon F, Clappier E, Arfeuille C, et al. Minimal residual disease quantification in ovarian tissue collected from patients in complete remission of acute leukemia［J］. Blood, 2021, 137(12): 1697－1701.
［25］Zver T,　 Frontczak S, Poirot C, et al. Minimal residual disease detection by multicolor flow cytometry in cryopreserved ovarian tissue from leukemia patients［J］. J Ovarian Res, 2022, 15(1): 9.
［26］Shirai R, Osumi T, Keino D, et al. Minimal residual disease detection by mutation-specific droplet digital PCR for leukemia/lymphoma［J］. Int J Hematol, 2023, 117(6): 910－918.
［27］Dolmans M M, Donnez J, Cacciottola L. Fertility preservation: the challenge of freezing and transplanting ovarian tissue［J］. Trends Mol Med, 2021, 27(8): 777－791.
［28］Cadenas J, La Cour Poulsen L, Mamsen L S, et al. Future potential of in vitro maturation including fertility preservation［J］. Fertil Steril, 2023, 119(4): 550－559.
［29］Practice Committees of the American Society for Reproductive Medicine, The Society of Reproductive Biologists and Technologists, The Society for Assisted Reproductive Technology. in vitro maturation: a committee opinion［J］. Fertil Steril, 2021, 115(2): 298－304.
［30］Braam S C, Ho V N A, Pham T D, et al. In-vitro maturation versus IVF: a cost-effectiveness analysis［J］. Reprod Biomed Online, 2021, 42(1): 143－149.
［31］Silber S J, Goldsmith S, Castleman L, et al. In-vitro maturation and transplantation of cryopreserved ovary tissue: understanding ovarian longevity［J］. Reprod Biomed Online, 2022, 44(3): 504－514.
［32］Ruan X, Cheng J, Korell M, et al. Ovarian tissue cryopreservation and transplantation prevents iatrogenic premature ovarian insufficiency: first 10 cases in China［J］. Climacteric, 2020, 23(6): 574－580.
［33］Byrne J, Grabow D, Campbell H, et al. PanCareLIFE: the scientific basis for a european project to improve longterm care regarding fertility, ototoxicity and healthrelated quality of life after cancer occurring among children and adolescents［J］. Eur J Cancer, 2018, 103: 227－237.
［34］Poirot C, Abirached F, Prades M, et al. Induction of puberty by autograft of cryopreserved ovarian tissue［J］. Lancet, 2012, 379(9815): 588.
［35］Ernst E, Kjærsgaard M, Birkebæk N H, et al. Case report: stimulation of puberty in a girl with chemo- and radiation therapy induced ovarian failure by transplantation of a small part of her frozen/thawed ovarian tissue［J］. Eur J Cancer, 2013, 49(4): 911－914.
［36］Rodriguez-Wallberg K A, Milenkovic M, Papaikonomou K, et al. Successful pregnancies after transplantation of ovarian tissue retrieved and cryopreserved at time of childhood acute lymphoblastic leukemia - a case report［J］. Haematologica, 2021, 106(10): 2783－2787.
［37］Poirot C, Brugieres L, Yakouben K, et al. Ovarian tissue cryopreservation for fertility preservation in 418 girls and adolescents up to 15 years of age facing highly gonadotoxic treatment. Twenty years of experience at a single center［J］. Acta Obstet Gynecol Scand, 2019, 98(5): 630－637.
［38］Dolmans M M, Hossay C, Nguyen T Y T, et al. Fertility preservation: how to preserve ovarian function in children, adolescents and adults［J］. J Clin Med, 2021, 10(22): 5247.
［39］Demeestere I, Simon P, Dedeken L, et al. Live birth after autograft of ovarian tissue cryopreserved during childhood［J］. Hum Reprod, 2015, 30(9): 2107－2109.
［40］Matthews S J, Picton H, Ernst E, et al. Successful pregnancy in a woman previously suffering from β-thalassemia following transplantation of ovarian tissue cryopreserved before puberty［J］. Minerva Ginecol, 2018, 70(4): 432－435.
［41］Colmorn L B, Pedersen A T, Larsen E C, et al. Reproductive and endocrine outcomes in a cohort of Danish women following auto-transplantation of frozen/thawed ovarian tissue from a single center［J］. Cancers (Basel), 2022, 14(23): 5873.
［42］Ruan X, Du J, Lu D, et al. First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency［J］. Climacteric, 2021, 24(6): 624－628.
［43］Ruan X, Du J, Lu D, et al. First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency［J］. Climacteric, 2022, 25(4): 421－424.
［44］Lotz L, Bender-Liebenthron J, Dittrich R, et al. Determinants of transplantation success with cryopreserved ovarian tissue: data from 196 women of the FertiPROTEKT network［J］. Hum Reprod, 2022, 37(12): 2787－2796.
［45］金凤羽, 阮祥燕, 杜娟, 等. 中国首个卵巢组织冻存库冻存患者特征及冻存效果分析［J］. 首都医科大学学报, 2021, 42(4): 521－525.
［46］阮祥燕, 程姣姣, 杜娟, 等. 子宫内膜癌卵巢组织冻存自体移植1例报道［J］. 中华生殖与避孕杂志, 2021, 41(7): 644－649.
［47］Dittrich R, Hackl J, Lotz L, et al. Pregnancies and live births after 20 transplantations of cryopreserved ovarian tissue in a single center［J］. Fertil Steril, 2015, 103(2): 462－468.
［48］Khiat S, Bottin P, Saïas-Magnan J, et al. Fertility preservation strategies for rectal cancer in reproductive-age women［J］. Future Oncol, 2019, 15(22): 2635－2643.
［49］Taylor H S, Kotlyar A M, Flores V A. Endometriosis is a chronic systemic disease: clinical challenges and novel innovations［J］. Lancet, 2021, 397(10276): 839－852.
［50］Donnez J, Squifflet J, Dolmans M M, et al. Orthotopic transplantation of fresh ovarian cortex: a report of two cases［J］. Fertil Steril, 2005, 84(4): 1018.e1－1018.e3.
［51］Sänger N, Menabrito M, Di Spiezo Sardo A, et al. Fertility preservation counselling for women with endometriosis: a European online survey［J］. Arch Gynecol Obstet, 2023, 307(1): 73－85.
［52］Calagna G, Corte L D, Giampaolino P, et al. Endometriosis and strategies of fertility preservation: a systematic review of the literature［J］. Eur J Obstet Gynecol Reprod Biol, 2020, 254: 218－225.
［53］Oktay K, Oktem O. Ovarian cryopreservation and transplantation for fertility preservation for medical indications: report of an ongoing experience［J］. Fertil Steril, 2010, 93(3): 762－768.
［54］Schallmoser A, Einenkel R, Färber C, et al. Cryostorage of human ovarian tissue: evaluating the storage and disposal pattern over a 22-year period in 2475 patients［J/OL］. Reprod Biomed Online, 2023: 103239. (2023－05－27)［2023-06-06］. https://pubmed.ncbi.nlm.nih.gov/37400319/.
［55］Fabbri R, Vicenti R, Magnani V, et al. Cryopreservation of ovarian tissue in breast cancer patients: 10 years of experience［J］. Future Oncol, 2012, 8(12): 1613－1619.
［56］Donnez J, Dolmans M M. Fertility preservation in women［J］. N Engl J Med, 2017, 377(17): 1657－1665.
［57］Von Wolff M, Sänger N, Liebenthron J. Is ovarian tissue cryopreservation and transplantation still experimental? It is a matter of female age and type of cancer［J］. J Clin Oncol, 2018, 36(33): 3340－3341.
［58］Lambertini M, Del Mastro L, Pescio M C, et al. Cancer and fertility preservation: international recommendations from an expert meeting［J］. BMC Med, 2016, 14: 1.
［59］Ulrich N D, Raja N S, Moravek M B. A review of fertility preservation in patients with breast cancer［J］. Best Pract Res Clin Obstet Gynaecol, 2022, 82: 60－68.
［60］中国人体健康科技促进会生育力保护与保存专业委员会, 国际妇科内分泌学会中国妇科内分泌学分会. 造血干细胞移植女童患者生育力保护中国专家共识［J］. 中国临床医生杂志, 2022, 50(9): 1027－1032.
［61］Ruan X. Expert consensus on fertility preservation in hematopoietic stem cell transplantation in girls in China［J］. Gynecol Endocrinol, 2023, 39(1): 2146671.
［62］Biasin E, Salvagno F, Berger M, et al. Ovarian tissue cryopreservation in girls undergoing haematopoietic stem cell transplant: experience of a single centre［J］. Bone Marrow Transplant, 2015, 50(9): 1206－1211.
［63］Torella M, Riemma G, De Franciscis P, et al. Serum anti-Müllerian hormone levels and risk of premature ovarian insufficiency in female childhood cancer survivors: systematic review and network meta-analysis［J］. Cancers (Basel), 2021, 13(24): 6331.
［64］Wikander I, Lundberg F E, Nilsson H, et al. A prospective study on fertility preservation in prepubertal and adolescent girls undergoing hematological stem cell transplantation［J］. Front Oncol, 2021, 11: 692834.
［65］Kyono K, Hashimoto T, Toya M, et al. A transportation network for human ovarian tissue is indispensable to success for fertility preservation［J］. J Assist Reprod Genet, 2017, 34(11): 1469－1474.
［66］Ozimek N, Salama M, Woodruff T K. National oncofertility registries around the globe: a pilot survey［J］. Front Endocrinol (Lausanne), 2023, 14: 1148314.
［67］Von Wolff M, Dittrich R, Liebenthron J, et al. Fertility-preservation counselling and treatment for medical reasons: data from a multinational network of over 5000 women［J］. Reprod Biomed Online, 2015, 31(5): 605－612.
［68］Ataman L M, Rodrigues J K, Marinho R M, et al. Creating a global community of practice for oncofertility［J］. J Glob Oncol, 2016, 2(2): 83－96.
［69］Woodruff T K. The Oncofertility Consortium-addressing fertility in young people with cancer［J］. Nat Rev Clin Oncol, 2010, 7(8): 466－475.
［70］Liebenthron 　J, Montag M, Reinsberg J, et al. Overnight ovarian tissue transportation for centralized cryobanking: a feasible option［J］. Reprod Biomed Online, 2019, 38(5): 740－749.
［71］Isachenko E, Isachenko V, Nawroth F, et al. Effect of long-term exposure at suprazero temperatures on activity and viability of human ovarian cortex［J］. Fertil Steril, 2009, 91(4 Suppl): 1556－1559.
［72］Liebenthron J, Montag M. Chapter 15 development of a nationwide network for ovarian tissue cryopreservation［J］. Methods Mol Biol, 2017, 1568: 205－220.

[1]	Wang Yuejiao, Ruan Xiangyan, Gu Muqing, Wei Yun, Guan Yuwei, Zhao Yue, Alfred O.Mueck. PGRMC1 as a potential biomarker of breast cancer risk for menopausal hormone therapy [J]. Journal of Capital Medical University, 0, (): 589-593.
[2]	Tian Xuanxuan, Ruan Xiangyan, Zhao Yue, Jin Jing, Liu Shunyu, Jiang Lingling. Effect of individualized lifestyle intervention on sexual function in obese patients with polycystic ovary syndrome [J]. Journal of Capital Medical University, 2025, 46(4): 614-619.
[3]	Zhao Yue, Ruan Xiangyan, Zou Liying, Ma Jun, Wang Yuejiao, Tian Xuanxuan, Jin Jing. Correlation between thyroid autoimmunity and gestational diabetes mellitus in Chinese euthyroid women [J]. Journal of Capital Medical University, 2025, 46(4): 626-631.
[4]	Ma Jun, Ruan Xiangyan, Xu Zhongting , Zhao Yue , Wang Yuejiao, Alfred O.Mueck, . Clinical efficacy of letrozole combined with Zi Gui Nv Zhen Capsules in patients with PCOS complicated by thin endometrium-induced infertility [J]. Journal of Capital Medical University, 2025, 46(4): 632-636.
[5]	Wang Jing, Zhou Qiaoyun, Wang Muyu, Xiao Yu, Song Dongmei, Guo Yan, Xia Enlan, Li Tinchiu, Huang Xiaowu. Analysis of risk factors and establishment of a prediction model for endometrial cancer in postmenopausal bleeding [J]. Journal of Capital Medical University, 2025, 46(1): 143-149.
[6]	Pei Youjuan, Ruan Xiangyan, Ju Rui, Wang Yuejiao, Jiang Lingling, Ma Jun. The application of artificial intelligence in the reproductive endocrinology [J]. Journal of Capital Medical University, 2024, 45(4): 566-572.
[7]	Li Yanglu, Ruan Xiangyan, Li Yanqiu, Gu Muqing, Du Juan, Wang Zecheng, Cheng Jiaojiao, Jin Fengyu, Jiang Lingling, Yang Yu, Alfred O. Mueck. Protective effect of N-Acetyl-L-Cysteine on cryopreserved-thawed human ovarian tissue [J]. Journal of Capital Medical University, 2024, 45(4): 573-582.
[8]	Wang Zecheng, Ruan Xiangyan, Yang Yu, Li Jing, Alfred O. Mueck. Changes in sexual hormone levels of iatrogenic premature ovarian insufficiency and its impact on glucose metabolism [J]. Journal of Capital Medical University, 2024, 45(4): 583-588.
[9]	Wang Zhikun, Ruan Xiangyan, Liu Lili, Yang Yu, Jiang Lingling, Wang Zecheng, Alfred O.Mueck. The impact of testosterone levels on female sexual function in menopausal transitional and postmenopausal women [J]. Journal of Capital Medical University, 2024, 45(4): 589-595.
[10]	Liu Lili, Ruan Xiangyan, Yang Yu, Jiang Lingling, Wang Zecheng, Zhang Mingzhen, Alfred O.Mueck. Correlation analysis between body composition and lumbar bone mineral density in perimenopausal and postmenopausal women [J]. Journal of Capital Medical University, 2024, 45(4): 596-601.
[11]	Zhao Yue, Ruan Xiangyan, Wang Yuejiao, Ma Jun, Jin Jing. Diagnostic value of multiple androgen indexes measured by LC-MS/MS for polycystic ovary syndrome [J]. Journal of Capital Medical University, 2024, 45(4): 602-608.
[12]	Tian Xuanxuan, Ruan Xiangyan, Jin Jing, Ju Rui, Du Juan, Cheng Jiaojiao, Yang Yu. Analysis of sexual function of patients with polycystic ovary syndrome with different clinical phenotypes [J]. Journal of Capital Medical University, 2024, 45(4): 616-622.
[13]	Jiang Lingling, Ruan Xiangyan, Li Yanqiu, Zhang Mingzhen, Wang Zecheng, Yang Yu , Liu Lili, Alfred O. Mueck. The impact of body composition on liver and kidney function and blood lipids in patients with polycystic ovary syndrome [J]. Journal of Capital Medical University, 2024, 45(4): 623-628.
[14]	Du Juan, Ruan Xiangyan. New progresses in ovarian tissue cryopreservation and transplantation [J]. Journal of Capital Medical University, 2024, 45(4): 629-635.
[15]	Wu Jianhong, Tian Yucui, Jiang Ziwen, Tang Shiqian, Liu Zhaohui, Dai Yinmei. The effect of lncRNA FAM95B1 on the pathogenesis of intrauterine adhesion by regulating insulin-like growth factor 2 [J]. Journal of Capital Medical University, 2023, 44(5): 821-827.

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments